Elevance Health (ELV) Revenue — Quarter Ended Sep 30, 2025
Revenue for the quarter rose compared to the prior quarter and also compared to the same quarter a year earlier. The improvement reflected continued growth in the company's core operations.
Key takeaway
Quarter ended Sep 30, 2025 · FY2025 Q3
Revenue for the quarter rose compared to the prior quarter and also compared to the same quarter a year earlier. The improvement reflected continued growth in the company's core operations.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$50.7B
Revenue reported for this quarter.
Quarter-over-quarter
+1.9%
Change from the immediately preceding quarter.
Year-over-year
+12.4%
Change from the comparable year-ago quarter.
Trailing four quarters
$194.8B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2024 | $45.4B | +6.6% |
| Mar 31, 2025 | $48.9B | +14.8% |
| Jun 30, 2025 | $49.8B | +13.4% |
| Sep 30, 2025 | $50.7B | +12.4% |
Revenue performance
Revenue increased from the immediately preceding quarter, maintaining the upward trajectory seen in recent periods.
Quarterly comparison
Compared with the same quarter one year earlier, revenue was higher, showing a larger year-over-year gain than the sequential change.
What to watch
Monitor whether the pace of revenue growth can be sustained given the competitive healthcare landscape.